Merck to acquire Harpoon Therapeutics for US$ 680 million
Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors
Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
Medway setup a state-of-the-art Heart Institute in Chennai
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
AHHL is primarily engaged in nursing care, in home primary care, physiotherapy at home, sample collection, post-operative/post-surgical care
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
Additionally, Rs. 12.85 crores shall be infused into the P H Diagnostic by way of either Equity or Loan to pay the existing debt
10+ emerging markets, Japan & ANZ transition in final phase
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
Subscribe To Our Newsletter & Stay Updated